RIBONUCLEIC ACID ISOLATION FROM HUMAN MONONUCLEAR CELL CULTURE WITH MAGNETIC BEADS PRE-ENRICHMENT FOR MOLECULAR ANALYSIS
Abstract
Introduction: In order to develop immunotherapies and therapeutic humoral molecules, ribonucleic acid (RNA) from cultured mononuclear cells (MNCs) is needed. However, it is not possible to isolate RNA using the standard mini column method from older MNC cultures. Therefore, the aim of this study was to develop a method to isolate RNA from MNC cultures, particularly older ones.
Materials and Methods: MNC cultures were grown from human buffy coats. The media from the cell culture was centrifuged to generate a pellet, to which CD45-specific magnetic beads were added. RNA was then isolated using the mini column method. The housekeeping gene beta-actin was used to confirm the success of RNA isolation through both real-time and conventional PCR tests.
Results: RNA was successfully isolated from MNC cultures, especially those that were a few months old, after pre-enrichment with magnetic beads. Without the magnetic bead pre-enrichment step, RNA isolation was not achieved. The results of the housekeeping gene tests indicated successful RNA isolation in all cases through both real-time and conventional PCR. Additionally, spectrophotometric values of the isolated RNA confirmed successful isolation.
Conclusion: This study is the first to demonstrate that it is possible to isolate RNA from human MNC cultures, particularly older ones, using specific magnetic beads. This method opens new opportunities for conducting genetic analyses, biomarker confirmation, and the development of antibodies.
References
Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007; 28(6): 766–72. doi:10.1093/eurheartj/ehl509.
Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020; 27(1):1. doi: 10.1186/s12929-019-0592-z.
Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004; 109(13):1615-22. doi: 10.1161/01.CIR.0000124476.32871.E3.
Hombach A, Hombach AA, Abken H. Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response. Gene Ther. 2010; 17(10):1206-13. doi: 10.1038/gt.2010.91.
Levine BL, Miskin J, Wonnacott K, Keir C. Global Manufacturing of CAR T Cell Therapy. Mol Ther Methods Clin Dev. 2016;4:92-101. doi: 10.1016/j.omtm.2016.12.006.
Fibriansah G, Lok SM. The development of therapeutic antibodies against dengue virus. Antiviral Res. 2016; 128:7-19. doi:10.1016/j.antiviral.2016.01.002.
Wolf C, Köppert S, Becza N, Kuerten S, Kirchenbaum GA, Lehmann PV. Antibody levels poorly reflect on the frequency of memory B cells generated following SARS-CoV-2, seasonal Influenza, or EBV Infection. Cells. 2022; 11(22):3662. doi: 10.3390/cells11223662.
Lee KO, Park MY, Kim LH, Seong HS, Park BH, Jeong SJ. Pandemic novel influenza a (H1N1) virus in Korea: the experience from august to september 2009. Korean J Clin Lab Sci. 2009; 41:145-52.
Muller MG, George AR, Walochnik J. Acinetobacter baumannii in localised Cutaneous Mycobacteriosis in Falcons. Vet Med Int 2010; 2010: 321797. doi: 10.4061/2010/321797
Bhatia S. Pitfalls found in SARS CoV-2 specific test performance during the comparison between WHO recommended method and a commercial test. Atlantic J Med Sci Res 2023;3(1):22-6. doi:10.5455/atjmed.2022.12.024.
Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990; 28(3):495-503. doi: 10.1128/jcm.28.3.495-503.1990.
Bhatia S. 2-3% fetal calf serum in cell media is sufficient for the development and growth of human mononuclear cell cultures. Atlantic J Med Sci Res. 2023;3(2):46-9. doi: 10.5455/atjmed.2023.01.06.
Bhatia S, Baersch G. Rapid isolation of mononuclear cells with high yield from minimal blood volumes: a simplified and robust approach for immunotherapeutic applications. Med Sci Discov. 2023; 10(10):838–41. doi:10.36472/msd.v10i10.1062.
Bhatia S. Loss of an abundant quantity of ribonucleid acid during mini column isolation method. Biotechnologia Acta. 2023; 16(3):65-9. doi:10.15407/biotech16.03.065
Copyright (c) 2024 Sanamed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal Sanamed is published under an Open Access license. All its content is available free of charge. Users can read, download, copy, distribute, print, search the full text of articles, as well as establish HTML links to them, without having to seek the consent of the author or publisher.
The right to use content without consent does not release the users from the obligation to give the credit to the journal and its content in a manner described under CC BY.